Martin Dow Group and Pharma Bureau have presented 5,760 coronavirus testing kits worth Rs13 million to the Indus Hospital.
Imported from the UK, the kits are best coronavirus testing procedures globally, according to a press release issued by Pharma Bureau on Thursday.
Ali Akhai, chairman of Martin Dow, along with Syed Wajeehuddin, chairman of Pharma Bureau, and Ayesha Haq, executive director of Pharma Bureau, presented the kits to Dr Abdul Bari, CEO of the Indus Hospital.
The testing kits will help build the hospital’s capacity. Kits are urgently needed by the Indus Hospital, the main focal point of the coronavirus campaign in Sindh
Ali Akhai said, “Contributing to community is one of the strongest values of Martin Dow and we are doing whatever we can to support organisations and government in the fight against this pandemic. These kits will surely help Indus Hospital to increase its reach.”
Syed Wajeehuddin said, “Being research-based pharmaceutical companies, members of Pharma Bureau are at the forefront of the battle to counter COVID-19 globally. In Pakistan too, our member companies are playing a pivotal role in equipping hospitals and helping other stakeholders in managing the situation.”
